Background: To date, more than 90 Streptococcus pneumoniae (S. pneumoniae) capsular serotypes are known. The prevalence of these serotypes varies according to the geographical area and the regional vaccination program. Due to the lack of regular vaccination programs for S. pneumoniae in developing countries, serotyping of the prevalent isolates is useful in selecting the correct vaccine. The present study aimed to evaluate common serotypes of pneumococcal meningitis in Bojnurd, Iran. Methods: All cerebrospinal fluid (CFS) samples suspected for bacterial meningitis were analyzed. The samples were collected during 2014-2018 in the Laboratory of Imam Reza Hospital (Bojnurd, Iran). Due to the high rate of false-negative cultures, polymerase chain reaction (PCR) was used for the detection of lytA and psaA genes of S. pneumoniae. In addition, the modified Marimon's PCR method was used for serotyping the bacteria. The data were analyzed using Pearson's Chi-square test. Results: Out of the 901 CSF samples, 106 cases tested positive for S. pneumoniae using the PCR method, while only 92 cases tested positive using the conventional methods. Based on the Marimon's PCR method, serotypes 23F, 19F, 19A, 1, 14, and serogroup 6A/B were the most common types. Serogroups 18C, 15A/F, 15B/C, 9A/V, 7A/F, 11A/D/F, and 22A/F were also detected in isolates. Note that 2.8% of the samples were non-typable (NT).
• Streptococcus pneumoniae is one of the major causative agents of meningitis in children. Pneumococcal conjugate vaccine is one of the best methods to prevent pneumococcal disease. • Pneumococcal capsular serotypes can vary in different geographical areas.
What's New • The first attempt to evaluate the most common capsular serotypes in northeast Iran. • Considering common capsular serotypes in Bojnurd (Iran), PCV-13 vaccine is the suitable choice for a vaccination program.
Introduction
Streptococcus pneumoniae (S. pneumoniae) is a Gram-positive coccus that can colonize the nasopharyngeal area without major clinical symptoms. Clinical manifestation of the bacteria ranges from otitis media and sinusitis to bacteremia, invasive pneumonia, and meningitis. 1, 2 S. pneumoniae causes more than 14 million cases of invasive infections and approximately one million deaths annually among children in developing and underdeveloped countries. During 1999-2010, in the Asian-Pacific region, the incidence of pneumococcal disease among children aged under two years was about 150 cases per 100,000. 3 Meningitis is defined as the inflammation of meninges surrounding the brain and spinal cord. Infectious agents that cause bacterial meningitis are S. pneumoniae, Neisseria meningitidis, and Hemophilus influenzae. Of these, S. pneumoniae is the most common agent. It has various virulence factors such as streptolysin-O, IgA protease, and polysaccharide capsule. The bacterium has more than 90 capsular serotypes, but only a limited number is related to acute pneumococcal meningitis. 4 The mortality rate due to meningitis among children and adults is 25-73% and 20-30%, respectively, and the survivors often suffer from neurological complications and sequelae. 4 The adverse effect depends on the patient's medical condition such as the underlying chronic disease, immune system, nutrition, etc. 5, 6 Considering the high morbidity and mortality rates associated with pneumococcal infections, it is important to implement life-saving programs for the prevention, timely diagnosis, and treatment of pneumococcal diseases. As part of a national vaccination program, two types of vaccines are currently used in developed countries, namely pneumococcal capsular vaccine-10 (PCV-10) and pneumococcal capsular vaccine-13 (PCV-13). These vaccines contain serotypes [1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F] and [1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F], respectively. 7 The production of PCV-7, the previous type of PCV vaccine, has already been stopped.
In some developing countries, such as Iran, pneumococcal vaccination is not included in the national vaccination program. Therefore, data on serotypes causing invasive pneumococcal infections are not readily available since vaccination is carried out locally in Iranian public and private hospitals. 4, 8 Patients with suspected meningitis are typically viewed as emergency cases and physicians immediately proceed with empirical anti-microbial therapy and obtain cerebrospinal fluid (CSF) for laboratory evaluations. In some cases, the CSF culture could be negative while other tests (e.g. serological and molecular diagnostic) could be positive. Consequently, methods such as polymerase chain reaction (PCR) and multiplex PCR are also used. 9 Since the prevalence of serotypes causing invasive pneumococcal infections varies in different geographical areas, we focused our study on patients suspected of meningitis in Bojnurd, Iran. Using the molecular method, we evaluated CSF samples for pneumococcal serotypes to recommend a regional vaccination program.
Materials and Methods
An observational and descriptive study of CSF samples from patients with suspected meningitis was conducted in the Laboratory of Imam Reza Hospital, Bojnurd, Iran. The samples were collected during 2014-2018 from children aged <5 years with an increased level of C-reactive protein (CRP) or with fever and CSF leukocytosis. The samples were evaluated for S. pneumoniae using conventional methods, including CSF sediment gram staining, microscopic evaluation, and culture. The PCR assay was performed using lytA (N-acetylmuramoyl-L-alanine amidase) and psaA (pneumococcal surface adhesin A) as marker genes. In addition, capsular serotypes were determined using the modified Marimon's multiplex PCR method for wzy, wchE, and wciN beta genes.
The inclusion criteria were different physical examinations for children <12 months and for those between 12 months and 5 years old, such as bulging fontanel, nuchal rigidity, and positive Brudziński signs. The general inclusion criteria were increased levels of CRP, CSF leukocytosis, CSF protein; reduced level of CSF glucose; and physical signs of fever, neck stiffness, vomiting, headache, etc. The exclusion criterion was a previous PCV vaccination. The data were analyzed with Pearson's Chi-square test using SPSS software (version 22.0). P<0.05 was considered statistically significant.
The study was approved by the Ethics Committee of North Khorasan University of Medical Sciences, Bojnurd, Iran (code: 95/P/970). Written informed consent was obtained from the parents of the children.
Genomic DNA Extraction
Total genomic DNA of the CSF samples was extracted using QIAamp® DNA Blood mini kit (QIAGEN, Germany). In accordance with the manufacturer's instruction, lysozyme at the concentration of 20 units/ml (SinaClon, Iran) was added to the lysis buffer. To obtain better results, based on a previous study, 10 the CSF samples were centrifuged at 8,000 rpm for 3 minutes and then used as the precipitants for DNA extraction. 10 
PCR Assay
The PCR assay was performed using the TAKARA PCR thermal cycler Gradient TP600 (TAKARA, Japan). For all PCR reactions, EmeraldAmp ® MAX PCR Master Mix 2X (Takara, Japan) in a volume of 50 µl was used.
PCR Assay for Detection of S. pneumoniae
The lytA and PsaA genes were selected as marker genes for the detection of S. pneumoniae. PCR was performed with the following sequences: primary denaturation at 94 °C for 5 minutes, 35 cycles of amplification (denaturation at 94 °C for 30 seconds, annealing at 58 °C for 30 seconds, extension at 72 °C for 30 seconds), and a final extension at 72 °C for 7 minutes. ATCC ® 33400 reference strain was used for PCR optimization and to determine the limit of detection (LOD) of the triplex PCR method. The third set of primers was added to the reaction as the internal control for preventing false-negative results. Specific primers were used as the control for the recognition of the human beta-globin gene. The list of primer sequences is described in table 1.
To assess the LOD, 10-fold serial dilutions (equivalent to 10 7 -10 1 copies) of a pneumococcal reference strain ATCC ® 33400 were prepared using tested sterile CSF as a solvent (due to the presence of human cells containing the beta-globin gene as the internal control) and the extracted DNA was tested by triplex PCR protocol. In positive reactions, the bands 268 (internal control), 187 (lytA), and 114 bp (psaA) were observed (figure 1). In negative reactions, only the internal control band (268 bp) was observed (table 2). The primers were evaluated using the software packages AlleleID 6.0 (Biosoft International, Palo Alto, CA, USA) and Oligo 6.0 (Life Science Software Resource, Minnesota, USA). The reactions without any PCR product bands were false-negative and the results were not reliable (table 2). As shown in figure 1 and table 3, the mean LOD of the reaction after triplicate testing was between 10 1 -10 2 colony-forming unit (CFU).
The PCR was also performed on 51 clinical isolates of S. pneumoniae and all reactions tested positive for lytA and psaA genes; indicating 100% sensitivity. For the specificity evaluation, PCR was performed using the extracted DNA from Haemophilus influenzae (ATCC51907), Neisseria meningitidis (ATCC13077), Staphylococcus aureus (ATCC19323), Streptococcus 12 PsaA reverse 5'-GACCAGAAGTTGTATCTTTTTTTCCG-3' Beta-globin forward 5'-GAAGAGCCAAGGACAGGTAC-3' 268 bp Present study Beta-globin reverse 5'-CAACTTCATCCACGTTCACC-3' 1 N-acetylmuramoyl-L-alanine amidase, 2 S. pneumoniae surface adhesin A precursor, 3 Base pair Figure 1 : Agarose gel electrophoresis of triplex PCR on standard samples. The 268 bp, 187 bp, and 114 bp bands belong to betaglobin, lytA, psaA genes, respectively. Lanes, 1: 100 bp ladder; 2: 10 7 copy; 3: 10 6 copy; 4: 10 5 copy; 5: 10 4 copy; 6: 10 3 copy; 7: 10 2 copy; 8: 10 1 copy of S. pneumoniae genome.
viridance
(ATCC6249), Enterococcus fecalis (ATCC29212), Enterococcus faecium (ATCC700221), Escherichia coli (ATCC25922), Streptococcus agalactiae (ATCC13813), Listeria monocytogenes (ATCC19115), Pseudomonas aeruginosa (ATCC10145), and Mycobacterium tuberculosis (ATCC25177). All reactions were negative.
Multiplex PCR for Determination of Capsular Serotypes
The primers used for the amplification of various capsular types (wzy, wchE, and wciN genes) are listed in table 4. Marimon's method was modified and adapted to the conventional PCR and agarose gel electrophoresis settings. 9 Originally, Marimon designed 55 sets of primers for evaluation with a capillary electrophoresis system. However, in the absence of such a system, due to the similar size of the PCR products of different primer pairs in the Marimon's method, we performed the evaluation with the conventional PCR and electrophoresis. The 55 pairs of primers were grouped into nine separate multiplex reactions based on the difference in their PCR product size. The optimum difference in size for detection in agarose gel electrophoresis was about 100 bp. In some cases, when grouping based on product size was not possible, the PCR products were evaluated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The PCR thermal cycling condition was 15 minutes at 95 ºC; 35 cycles of 60 seconds at 95 ºC, 60 seconds at 58 ºC, and 60 seconds at 72 ºC; and a final extension step of 10 minutes at 72 ºC.
Results
Out of the 901 CSF sample, 92 cases tested positive for S. pneumoniae in culture and 106 cases tested positive for lytA and psaA genes using the molecular detection method. It should be noted that all the 92 culture-positive samples also tested positive in PCR. Of the 106 (11.8%) positive samples, 50 (47.2%) and 56 (52.8%) isolates were from female and male patients, respectively. There was no significant correlation between sex and S. pneumoniae isolation (P=0.92). Based on the primer pair combinations in table 1, all positive samples were evaluated for capsular serotypes using the modified Marimon's multiplex PCR method. As shown in figure 2 , the types 23F, 19F, 19A, 1, 14, and group six were the most common serotypes and groups in our samples. It should be noted that 2.8% of the samples were Non-typable (NT). The results for capsular serotypes and their distribution are presented in figure 2 and table 5.
Discussion
Serotypes 23F, 19F, 1, 14, 19A, and serogroup 6 were the most common types in Bojnurd, Iran. PCV13 had the optimal coverage for children aged ≤5 years in this area. The Quellung reaction (Neufeld test) is the accepted gold standard method for S. pneumoniae serotyping. However, a number of factors (e.g., costs, the need for operational expertise, potential falsenegative cultures especially in meningitis cases) hindered its use in clinical laboratory settings. 11 Molecular assays have recently been developed to identify the invasive pneumococcal disease (IPD) associated with serotype distribution. 9, 12 Consequently, we used the modified Marimon's molecular method for serotyping S. pneumoniae. A limited number of capsular serotypes were related to most of the IPDs. 13 In the present study, we found 13 serotypes, which were responsible 1  14  84  CCGTCTTTTTGTATGGTGCTATG  TGAACAGCCAATCCATCAATCAG  22A, 22F  181  ACGTATAGGACGTTTCTCAATCC  ATCCCGAAACCAAATTGCTATCC  33C  278  CGGCAGGTATAAGTATTATCGG  CCTACACCTCTTATAAACGTTGG  35F, 47F  375  TTGCTACAGTTTTGATGTATCTCC  AGAATCCGTTTCATCATACAGCC  6C, 6D  473  GTCGTGTAAAGTAGTATACAATCC  ATAATCCTCTGGATTATCCACCC  24A, 24B, 24F  569  TCATGCTTATGTTATGTGTTACGG  GTGAGAGCTATATTTAGAACATGG  23B  650  TTGCATATGGATTTAATGGTGGG  ACCATTGCTGATAGAAGTAGAGG  2  8  94  ATTAGCTGCATACGCAAGAACC  ATTAGCTGCATACGCAAGAACC  3  191  AGAAATGCTATCCGCGTTGGG  TTGTCACGAGATTACGCTCAGG  20  292  TATTGTTCCGAAAAAAGAGTGGG  TACTCAAAGATTGTGTGGTACGG TCCAACAACTAACCTTATAAGGG  23A  314  CTAGGTTCGTATCTCTTTGCGG  TACCAAATGGGTAATGGAGGGG  41A, 41F  413  AGTTACTGGCCCTTTCTTATTCC  AGGTAAAAAGTCATATCCATTCCC  19F  523  TGTTCTTAGTAATGGATATACGGG  AAAACTTCACCAGGATCTAATGG  17A  615  TTTACCCAAGAATGGTTTCTAGG  AGCATAACAGTTTGCGCTATTGG  5  21  122  TTATGCTGGTTTAAATATCGCTCC  TAACAAATATGCCAAAACGTAGCC  34  130  TGTAAGAGGAGATTATTTTCACCC  GTCACAATAAAAACTGTACCTCC  25A, 25F, 38  140  CAACACAATGTCTTATTGCAGCC  AACGCACCCCAAAATAACTTTCC  27  240  AATGCCGACGATTAATGCAGCC  CTAGCCATGCTGGATATTTCCC  19B, 19C  338  TCAGTACGAATAGATGGAACACC  CCCAGTATCTAAATCCTAATCCC  4  433  ATTCAGAGGCAGCTAGTTCAGG  CAGAAGCTACTGTTAGGCTGG  48  532  CCCTTTGATAGCTATAGTATCGG  CCCTGGAATAGAAGTTTTCTAGG  12A, 12B, 12F, 44, 46  627  CCTTTCTGATTCGTCCAGTTCC  AGTTGAACCAACTCCCCATCC  6  10A, 10B, 0C, 10F  151  CRATGAGGCTATATGTTGGAATAG  GTATTGAACYCATAGATAACAGAG  29  251  TGTGGCAAAAATTTCTTTAGCGG  ATATACCCAGTAAACAGACAAGG  11A, 11D, 11F  348  GGACATGTTCAGGTGATTTCCC  TGCGCCAAATTTGGTATCGACC  5  443  TTATCTATTTTATCGCAGACTCCC  CTGCCGATAAAAAGATAGATGCC  39  544  TATGAGGTATCATTTAGCAGGGG  ATCATCGAAATGGCAACTAAAGG  33B, 33D  640  ACAACAGCAATGTTGTTGTTACTC  GAGAAGTAAGAGTTTTGTCATCC  7  43  160  GGAATAGTTTAGGATTTGTACACC  TAGAGTCTGCTAACTGTAATATCC  23F  260  TTCACAAGTGATAGTGAACTTGG  TATTAGCTTTATCGGTAAGGTGG  32A, 32F  357  CTTACAATGAGACGCTATTTTCC  GTTATTACCATTGAATTCGTTCCC  33A, 33F, 37  453  ATGTTAGATTAGATGGTTTGCTGG  ATTCAACACATAAACCGTTGGGG  1  555  TTTGCTAGATGGTGAGTTTGTATC  TTTAGAAGCTGCATTGTACTACTC  36  230  TTCCGGATCTATTCAATTTCCCC  CAATAACAGCCTCCGTTTTACC  2  383  GTTCAATATTTCTCCACTACACC  CTAAGAGTTCCAATACGTTGACC  35B  483  CATTAGTGTTGCTATGTTGTTCC  GATTAGATAAATAAATACGCCCCC  16F  606  ACTGCTTGCATATTAGCTTTATGG  TGATAGAGTGACAGAACAATTGG  8  9A, 9V  172  GATCAATGGCAACTATATTTACCC  GATTCACTGTCTGACTTTGAACC  19A  269  ATTGGAGTAGCTGAGGTTTTTGG  TATCCAATTTAAAACCAGCACGG  35A, 35C, 42  367  TCGTTCACCTACTTTATTAATGCC  AATAATTCCTAATACCATCTGCCC  45  463  CAGATTGGTTTTCACATCACTCC  ACATAACACGACTTTTAGTGACC  9  18A, 18B, 18C, 18F  220  AGTCTTACTAGACGTAATGAACC  AAGATAAATTGACTAAGTCCTCCC  13  328  TTAACAGGTAGATTACGACTTGG  ATATCCCAAAAACAAAATCGCTGG  47A 423 AATACATTGTACGTCTTTAACCCC CGAAGAATTAAACCCACATAACC bp: Base pair for all meningitis cases. Note that 2.8% of the isolates were NT.
During the last two years, the prevalence of some serotypes (9A/V, 15A/F, 7A/F, 1, 11A/D/F and 22A/F) has increased in Bojnurd, Iran. Studies in the USA, UK, and Brazil have reported that only a few pneumococcal serotypes were related to the colonization and invasive diseases, [14] [15] [16] whereas a wide variety of such serotypes were identified in Asia. 17, 18 The serotypes 23F, 14, 19F, and 6B were predominant in East and Southeast Asia prior to the PCV vaccination. 3 Several studies have reported that serotypes 1, 4, 6A/B, 7F, 9V, 14, 15B/C, 18C, 19F, 19A, and 23F account for more than 80% of the IPD in children, especially in developing countries without any routine pneumococcal vaccination programs. [19] [20] [21] [22] In the absence of such programs in Iran, we managed to identify the presence of serotypes 23F, 19A, 19F, 18C, 14, 1, and serogroups 6A/B, 15B/C, 9A/V, 15A/F, 7A/F, 11A/D/F, and 22A/F. In line with other studies, 1, 4, [23] [24] [25] [26] we found that the most prevalent serotypes in meningitis cases were 23F, 19A, 19F and 6A/B, which could be controlled with the PCV-13 vaccine. In contrast, Talebi and colleagues reported that the most common serotypes in pneumococcal isolates were 14 and 3, followed by 23F and 19F. 27 Some researchers believe that the common serotypes in infants are different from those found in adults. A previous study reported that the serotypes 6 and 19 were common in IPD related isolates and the 23-valent vaccine was best for adults. 28 Moreover, in another study, they reported serotype 6 was most prevalent in adults, but serotype 19 in infants. 29 Dashti and colleagues reported that the most prevalent serotypes were 19, 6, 14, 17, 20, 23 , and 21 in nasopharyngeal carriers under 10 years old in Tehran (Iran). 30 Another study reported that four serotypes of 19A, 6, 3, and 23F were common in both the carrier and clinical samples at a rate of at least 91%. 13 Gharailoo and colleagues reported that the serotypes 6A/B, 19A, 19F, and 23F were the common types of nasopharyngeal carriers, 31 whereas another study reported that the most common serotypes in nasopharyngeal carrier children were 19F, 6A/B, 15A, 11, 23F, 1, 19A, and 35B. 32 Based on the abovementioned studies, we deduced that the source of meningitis related to pneumococcal serotypes was the nasopharyngeal area. Overall, the data showed that serotypes 6A/B, 14, 18C, 19F, 19A, and 23F were the most prevalent serotypes in Asia, especially in non-immunized areas.
We found that PCV-13 vaccine is the best candidate against common serotypes of meningitis-related S. pneumoniae strains. This vaccine is readily available in Iran and covers 77.13% of the most common serotypes in our region, especially 23F, 19A, 19F, and 6A/B. On the other hand, PCV-10 vaccine covers 65.06% of the serotypes but excludes the two major serotypes 19A and 6A. None of these vaccines could cover serotypes 22, 7, 15A/F, 15B/C, and 11. The present study was the first attempt to identify the distribution of serotypes in Bojnurd. Serotyping on more specimens is recommended to determine the extent of their coverage and evaluate the effectiveness of the vaccine.
Conclusion
The high pathogenicity of S. pneumoniae in different age groups and the increasing antimicrobial resistance are alarming. The management of this pathogen is essential to protect lives and to reduce therapeutic treatment costs. PCV-13 vaccine is the preferred choice in northeast Iran. More research on serotypes in different geographical regions allows the design of a nationwide vaccination program. Further studies on capsular serotyping, antimicrobial susceptibility testing, and molecular epidemiology should provide a better understanding of common pneumococcal types and allow choosing optimal therapeutic strategies in Iran.
